3SBio Market Cap

3SBio has a market cap or net worth of 55.90 billion as of April 29, 2026. Its market cap has increased by 82.95% in one year.

Market Cap

55.90B

Enterprise Value

40.61B

Revenue

19.69B

Ranking

n/a

PE Ratio

5.86

Stock Price

22.22

Market Cap Chart

Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 55.90B, an increase of 146.59%. That is a compound annual growth rate of 8.64%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	55.90B	-7.44%
Dec 31, 2025	60.39B	321.75%
Dec 31, 2024	14.32B	-20.61%
Dec 29, 2023	18.04B	-10.89%
Dec 30, 2022	20.24B	23.46%
Dec 31, 2021	16.40B	-8.83%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shanghai Junshi Biosciences	43.42B
Biocytogen Pharmaceuticals (Beijing)	42.78B
Shanghai Henlius Biotech	42.15B
RemeGen	76.21B
Sino Biopharmaceutical	97.87B
Genscript Biotech	29.60B
Sichuan Kelun-Biotech Biopharmaceutical	109.41B
InnoCare Pharma	28.40B

Market Cap Rankings